SCHEMBL5338039

SCHEMBL5338039

CCc1ccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)cc(C(=O)N(C)C)cn23)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.45
AKT2 P31751 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.40
TSPO P30536 2/20 0.39
GMNN O75496 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
CENPE Q02224 1/20 0.38
CSNK1E P49674 1/20 0.38
PDK1 Q15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5337099 0.82 SMN1; SMN2 (0.44) AKT1AKT2SMN1; SMN2TSPOGMNN
SCHEMBL5341752 0.74 AKT1 (0.53) AKT1AKT2TSPOGMNNLMNA
SCHEMBL5318498 0.73 AKT1 (0.48) AKT1AKT2TSPOGMNNLMNA
SCHEMBL5337544 0.73 AKT1 (0.42) AKT1AKT2TSPOGMNNLMNA
SCHEMBL5342248 0.72 TSPO (0.47) AKT1AKT2SMN1; SMN2TSPO
SCHEMBL5357335 0.71 KDM4E (0.48) AKT1AKT2SMN1; SMN2TSPOGMNN
SCHEMBL5344567 0.69 SMN1; SMN2 (0.47) AKT1AKT2SMN1; SMN2TSPOGMNN
SCHEMBL5342211 0.67 SLC2A1 (0.47) SMN1; SMN2TSPOGMNNLMNAPOLB
SCHEMBL5351210 0.66 CNR1 (0.54) AKT1AKT2
SCHEMBL5335702 0.66 POLB (0.51) AKT1AKT2TSPOGMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007086080-A2 NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LIMITED (IN) 2007-08-02 WO claimed
WO-2007086080-A2 NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LIMITED (IN) 2007-08-02 WO disclosed